Nutriventia has closed a strategic growth investment from NDude Labs, an investment holding company focused on healthcare and wellness businesses, with operations in India and the United States.
The investment comes as global demand for clinically substantiated nutrition ingredients continues to grow, with brands and consumers increasingly seeking proof over promises. Evidence-led development has defined Nutriventia from the start, and this partnership allows us to take that approach into more markets and to more of the brands we serve.
Where the Investment Will Focus
- Clinical research: deepening our clinical R&D pipeline, so every ingredient remains anchored in published evidence.
- Ingredient innovation: expanding our portfolio of proprietary branded ingredients (TurmXTRA, Ashwanova (Prolanza), Melotime, CaffXtend, C-Fence and ALAXTRA) and scaling Nutriventia E.D.G.E., our low-dose delivery platform.
- Global presence: building a senior commercial team in the United States, ahead of further expansion into Europe and Asia-Pacific.
- Scientific leadership: broadening our scientific communication and thought leadership in key global markets.
For our partners, this means more clinical research behind our ingredients, new innovation in the pipeline and closer support in the markets where they operate.
Leadership Perspectives
“We built our proprietary delivery platforms to solve genuine pharmaceutical-grade challenges around bioavailability, stability and dosing efficacy. This partnership ensures that we can deepen our clinical pipeline and advance our delivery platforms without compromising on our scientific rigor.”
– Vishal Shah, Co-Founder & Managing Director, Nutriventia
“Every stage of Nutriventia’s growth has been anchored in one principle: lead with the science, and the market follows. This investment allows us to accelerate our global commercial reach, establish direct leadership on the ground, and deliver our clinically validated branded ingredients to top-tier wellness brands worldwide.”
– Rajat Mittal Shah, Co-Founder & Executive Director, Nutriventia
“Nutriventia represents the kind of business we want to partner with at NDude Labs: science-led, innovation-driven and built in India with the potential to become a global category leader. We believe NDude’s operating experience, relationships across India and the U.S., and AI-native approach can help accelerate Nutriventia’s next phase of growth.”
– Nitin Thakor, Managing Director, NDude Labs
About NDude Labs
NDude Labs is an investment holding company and operating partner focused on building category-leading healthcare and wellness businesses. With a presence in India and the United States, it combines patient capital, operating experience and an AI-native proprietary operating system to help its portfolio companies accelerate growth.
Investec served as financial advisor to Nutriventia on the transaction. Cyril Amarchand Mangaldas and Stratage Law Partners served as legal counsel. PwC served as due diligence advisor.
In the News
- The Economic Times: NDude Labs invests in nutraceutical ingredients firm Nutriventia
- Nutritional Outlook: Nutriventia Secures Growth Investment From NDude Labs to Expand Clinical Pipeline and US Operations
- Nutrition Insight: NDude Labs invests in Nutriventia to expand R&D and global reach
- Entrepreneur India: NDude Labs Invests in Nutraceutical Ingredients Company Nutriventia
Reviewed by Nikita Joshi
